SMMT Q1 2023 Earnings — Summit Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

SMMTSummit Therapeutics Inc.

$12B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$537M

Net Income

-$542M

EPS (Diluted)

$-1.43

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$255M

Total Liabilities

$121M

Stockholders' Equity

$133M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$250,000	-100.0%
Gross Profit	$0	$250,000	-100.0%
Operating Income	-$537M	-$22M	-2324.2%
Net Income	-$542M	-$21M	-2434.8%